CN1092969C - Anticancer Chinese medicine - Google Patents
Anticancer Chinese medicine Download PDFInfo
- Publication number
- CN1092969C CN1092969C CN00105792A CN00105792A CN1092969C CN 1092969 C CN1092969 C CN 1092969C CN 00105792 A CN00105792 A CN 00105792A CN 00105792 A CN00105792 A CN 00105792A CN 1092969 C CN1092969 C CN 1092969C
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- chinese medicine
- fructus
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention belongs to a traditional Chinese medicine for treating cancers. The traditional Chinese medicine has the functions of supporting healthy energy to eliminate evil, benefiting qi to generate blood, nourishing the liver and kidney, strengthening the spleen and stomach and resisting cancers for detoxification. Especially, the immune function of an organism is regulated. All the limbs and bones are irrigated so as to nourishing the five viscera and six bowels. The traditional Chinese medicine of the present invention is prepared from the medical materials of the preferable compounding ratio: 15 parts by weight of ginseng, 15 parts by weight of human placentae, 15 parts by weight of astragalus root, 15 parts by weight of wolfberry fruit, 15 parts by weight of angelica, 15 parts by weight of double blossom, 15 parts by weight of atractylodes ovata, 15 parts by weight of amomum fruit and 25 parts by weight of hawthorn. The traditional Chinese medicine is low in cost, thereby being taken by cancerous persons.
Description
The invention belongs to the Chinese medicine of treatment cancer.
Cancer is still in the world today coagulates difficult disease, and along with industrial expansion, the pollution of environment is the pollution of air particularly, and food, fruit, vegetable, grain, oil, water etc. are also polluted, and cancered people is more and more.Cancer serious harm human life and health bring tremendous influence for family and society.Cancerous cell is a kind of toxic cell, soak evil to internal organs, lymph, blood, bone lattice, just cause diffusion, pass on and move, focus is killed and wounded very strong to human body, cause that health is become thin suddenly, appetite minimizing, anemia, hematochrome be reduced in below 8 grams, leukocyte below 500, wave that body is unable, dysphoria and insomnia, nausea and vomiting, pale complexion, heart beating breathe hard.Excision, chemotherapeutic treatment, radiotherapy in the treatment are the main means of treatment cancer, excise the carcinoma kill cancer cell, alleviate disease, but meanwhile also kill many normal cells, bodily tissue is caused partial destruction, causes various side effect, the performance cardinal symptom be pain unbearably, heart beating is breathed hard, dry cough is spat, pale complexion, and misery is to the utmost point.Subdue above-mentioned disease though now have discrete medicine can treat cancer, these medicines select for use medical material expensive, and medicine is too expensive, has only small number of patients to use, and most patients can not use, and can not popularize.
It is lower that aim of the present invention provides a kind of price, is convenient to the Chinese medicine of the used treatment cancer of cancer patient.
Chinese medicine of the present invention be at the cancer patient because of each internal organs organ pipe of the cancer cell criminal of soaking, lymph, the cytogenetics genetic disorder causes pathological change, cell proliferation, QI and blood lifting imbalance, the negative and positive imbalance causes leukocyte to descend, hematochrome reduces, alopecia, and appetite reduces, nausea and vomiting, weak breath is unable, and health is become thin, and heart beating is breathed hard, cough is spat, and pain unbearably.This Chinese medicine is strengthening vital QI to eliminate pathogenic factors, hard masses softening and resolving, blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, Repercusion analgesia, invigorating the spleen and regulating the stomach, benefiting qi and nourishing blood, nourishing the liver and kidney, strong muscles and bones, conditioning flesh energy, tranquillizing and allaying excitement, treating both the principal and secondary aspects of a disease decomposes cancerous cell, and anticancer detoxifcation improves immune function of human body, changes gene and promotes the cell homergy.This Chinese medicine is strengthening vital QI to eliminate pathogenic factors, qi-supplementing, blood-engendering, nourishing the liver and kidney, invigorating the spleen and regulating the stomach, anticancer detoxifcation.Emphasis is to adjust body's immunological function, irrigates the extremity bones of the body collectively, to nourish the vital organs of the human body.For reaching above-mentioned effect, take to the property of the present invention is directed to following medicine: Radix Ginseng, Placenta Hominis, the Radix Astragali, Fructus Lycii are benefiting qi and nourishing blood, nourishing the liver and kidney conditioning function; The Rhizoma Atractylodis Macrocephalae, Fructus Crataegi, Fructus Amomi are invigorating the spleen and regulating the stomach; Chinese angelica blood supplementing blood-enriching and blood-promoting circulation Repercusion analgesia; Flos Lonicerae heat-clearing and toxic substances removing, detumescence.
Its medical material is formed the weight portion proportion relation:
Radix Ginseng 13-17 Placenta Hominis 13-17 Radix Astragali 13-17 Fructus Lycii 13-17
Radix Angelicae Sinensis 13-17 Flos Lonicerae 13-17 Rhizoma Atractylodis Macrocephalae 13-17 Fructus Amomi 13-17
Fructus Crataegi 23-27.
The weight portion proportion relation of the preferred Chinese crude drug of Chinese medicine of the present invention is:
Radix Ginseng 14-16 Placenta Hominis 14-16 Radix Astragali 14-16 Fructus Lycii 14-16
Radix Angelicae Sinensis 14-16 Flos Lonicerae 14-16 Rhizoma Atractylodis Macrocephalae 14-16 Fructus Amomi 14-16
Fructus Crataegi 24-26.
Medical material optimum weight part proportion relation of Chinese medicine of the present invention is:
Radix Ginseng 15 Placenta Hominiss 15 Radixs Astragali 15 Fructus Lycii 15 Radix Angelicae Sinensis 15 Flos Loniceraes 15
The Rhizoma Atractylodis Macrocephalae 15 Fructus Amomis 15 Fructus Crataegis 25.
The processing method for making of this Chinese medicine is that above-mentioned Chinese crude drug is cleaned with water purification, dry to be ground into meticulous end and to cross the 80-90 mesh sieve, powder.Add the Mel that refined, stir, make pill, every ball 10 grams are advisable.The Mel that adds with weather, the Mel kind is different and different.The weight portion proportioning of general Chinese medicine powder and Mel is 10: 10 to 10: 8.Being 10: 10 when the weight part ratio spring of Chinese medicine powder and Mel, summer, is 10: 9 when autumn, winter, and cold district is 10: 8.
Usage, three times on the one, each ball, one hour after meal boiled water clothes are down.
Taboo is avoided the greasy food that consumes oil, cigarette, is spilt, pungent, anger, the anti-flu of irritable food ， Only.
Chinese medicine of the present invention has following advantage through clinical use:
1, the medical material selected for use of the present invention is common nontoxic Chinese crude drug, does not have artificial compound, to human body
Nonhazardous.
2, to select medical material for use be common natural Chinese medicine to this Chinese medicine, do not have special expensive material, is particularly suitable for general action.
This Chinese medicine with Radix Ginseng, the Radix Astragali, purple scold car, Fructus Lycii be benefiting qi and nourishing blood, promoting the production of body fluid and inducing sedation of the mind, nourishing the liver and kidney, can invigorating QI to consolidate the body surface resistance, the phagocytic function that strengthens reticuloendothelial system is arranged, the effect that improves health immunity, anti-cancer, the function of reinforcing the kidney regains one's strength.Can make rate and blood-lipid decreased when being classified as the hemopoietic of enriching blood, aortic disease is had protective effect.The Rhizoma Atractylodis Macrocephalae, Fructus Amomi, Fructus Crataegi are row spleen invigorating the stomach and promoting digestion, calm vomiting, eliminating stasis to stop pain, removing mass disappear, the subside a swelling function of invigorating the spleen and regulating the stomach.Flos Lonicerae is heat-clearing and toxic substances removing, carbuncle furuncle abscess, the pathogenic fire purging effect relieves internal heat.Above-mentioned Chinese crude drug is combined together by suitable weight part ratio, strengthening vital QI to eliminate pathogenic factors, hard masses softening and resolving, blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, Repercusion analgesia, invigorating the spleen and regulating the stomach, benefiting qi and nourishing blood, nourishing the liver and kidney, strong muscles and bones, conditioning flesh energy, play and decompose cancerous cell, anticancer Detoxication, improve immune function of human body, change the function that gene promotes the cell homergy, reach the effect of control treatment of cancer cancer.
For showing the effect of Chinese medicine of the present invention to treatment for cancer, the present invention is through the clinical observation of 100 routine systems, and the cancer patient of different sexes is selected.Wherein male 52 examples, women 48 examples.Selected case stops other all treatments.Selected case all is diagnosed as terminal cancer diffusion lymphatic metastasis through various big hospital, through ultrasound diagnosis and radioisotope scan, CT scan, all fail to respond to any medical treatment, wherein have diffusion transfer to be decided to be the patient that life is no more than a year to pulmonary, brain, bone lattice through large hospital.11 years old of age minimum, maximum 84 years old, average 47.5 years old.The course of disease 52 examples above middle age, male's 32 examples, women's 20 examples.Course of disease produce effects 32 examples surpass four months male's 21 examples, women's 11 examples, and sb.'s illness took a turn for the worse 16 examples that the course of treatment is invalid, male's 9 examples, women's 7 examples see the following form.
For this universally acknowledged difficult disease of coagulating of cancer, be not easy to find, to finding has been late period, all treatment meanss only are the prolongation life that palliates the agonizing sufferings, most of cancer patients are from being found to death seldom above 1 year, this Chinese medicine surpasses the patient with advanced cancer course of disease and surpasses 50% more than half a year, the course of disease surpasses 20% above person more than a year, the course of disease is 8% above person more than 3 years, this Chinese medicine has obvious effects to cancer, and cost of material that this Chinese medicine is got is low, is particularly suitable for common cancer patient and uses, and have no side effect.
| Sum | Male's (example) | Women's (example) | |
| The observation number | 100 | 52 | 48 |
| The course of disease above person half a year | 52 | 27 | 25 |
| (wherein person more than a year) | (21) | (13) | (8) |
| (wherein person more than 3 years) | (8) | (5) | (3) |
| Produce effects | 32 | 16 | 16 |
| Invalid | 16 | 9 | 7 |
In order to describe Chinese patent medicine of the present invention in detail, enumerate following specific embodiment, but embodiment not a limitation of the present invention.
Embodiment
Take by weighing raw material (kilogram) by following weight proportion:
Radix Ginseng 1.5 Placenta Hominiss 1.5 Radixs Astragali 1.5 Fructus Lycii 1.5 Radix Angelicae Sinensis 1.5 Flos Loniceraes 1.5
The Rhizoma Atractylodis Macrocephalae 1.5 Fructus Amomis 1.5 Fructus Crataegis 2.5
Above-mentioned Chinese crude drug is ground into meticulous end crosses 90 mesh sieves, become powder.14.5 kilograms Mel heating is boiled, remove the fire of heating,, make medicine pill, every ball 10 grams by the conventional pill method for making of Chinese medicine with stirring in the thin medicated powder adding Mel.
Claims (5)
1 one kinds of Chinese medicines for the treatment of cancer is characterized in that it is the medicament of being made by the following weight proportion raw material
Radix Ginseng 13-17 Placenta Hominis 13-17 Radix Astragali 13-17 Fructus Lycii 13-17
Radix Angelicae Sinensis 13-17 Flos Lonicerae 13-17 Rhizoma Atractylodis Macrocephalae 13-17 Fructus Amomi 13-17
Fructus Crataegi 23-27.
The Chinese medicine of 2 treatment cancers according to claim 1, wherein the weight proportion of each raw material is
Radix Ginseng 14-16 Placenta Hominis 14-16 Radix Astragali 14-16 Fructus Lycii 14-16
Radix Angelicae Sinensis 14-16 Flos Lonicerae 14-16 Rhizoma Atractylodis Macrocephalae 14-16 Fructus Amomi 14-16
Fructus Crataegi 24-26.
The Chinese medicine of 3 treatment cancers according to claim 2, wherein the weight proportion of each raw material is:
Radix Ginseng 15 Placenta Hominiss 15 Radixs Astragali 15 Fructus Lycii 15 Radix Angelicae Sinensis 15 Flos Loniceraes 15
The Rhizoma Atractylodis Macrocephalae 15 Fructus Amomis 15 Fructus Crataegis 25.
4 Chinese medicines according to claim 1 or 2 or 3 described treatment cancers is characterized in that said medicament is a said dosage form on any pharmaceutics.
The Chinese medicine of 5 treatment cancers according to claim 4 is characterized in that said medicament is and the synthetic medicine pill of Mel.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00105792A CN1092969C (en) | 2000-04-11 | 2000-04-11 | Anticancer Chinese medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00105792A CN1092969C (en) | 2000-04-11 | 2000-04-11 | Anticancer Chinese medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1271584A CN1271584A (en) | 2000-11-01 |
| CN1092969C true CN1092969C (en) | 2002-10-23 |
Family
ID=4577945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN00105792A Expired - Fee Related CN1092969C (en) | 2000-04-11 | 2000-04-11 | Anticancer Chinese medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1092969C (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1118263A (en) * | 1994-09-06 | 1996-03-13 | 毕盛 | Life star-Chinese medicine for cancers |
| CN1119081A (en) * | 1994-09-23 | 1996-03-27 | 谢家治 | Pure Chinese medicine health beverage capable of regulating human immunologic function |
-
2000
- 2000-04-11 CN CN00105792A patent/CN1092969C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1118263A (en) * | 1994-09-06 | 1996-03-13 | 毕盛 | Life star-Chinese medicine for cancers |
| CN1119081A (en) * | 1994-09-23 | 1996-03-27 | 谢家治 | Pure Chinese medicine health beverage capable of regulating human immunologic function |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1271584A (en) | 2000-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100998843A (en) | Medicinal composition for treating cholecystitis | |
| CN1751734A (en) | Traditional Chinese medicine prepn. for treating lithiasis and its prepn. method | |
| CN1354014A (en) | Gongbu ointment | |
| CN111467459B (en) | Traditional Chinese medicine composition for treating novel coronavirus pneumonia at recovery stage, application and preparation method thereof | |
| CN1613383A (en) | Green healthy beverage | |
| CN1305515C (en) | Chinese medicinal powder and decoction composition for treating cancer | |
| CN115645451B (en) | Tibet bath composition, tibetan bath medicament, preparation method and use method | |
| CN1679892A (en) | Oral liquid for treating cancer and preparation thereof | |
| CN101322775B (en) | Chinese medicine for treating psoriasis | |
| CN109528966A (en) | A kind of health liquor and preparation method thereof | |
| CN1092969C (en) | Anticancer Chinese medicine | |
| CN108498568A (en) | Chinese patent drug, medical food and the preparation method of autoimmune and immune related diseases are treated with Goat Placenta or embryo | |
| CN108186794A (en) | A kind of Chinese medicine composition for treating malignant tumour and its preparation method and application | |
| CN1990033A (en) | Drug for treating hypertension, dense blood and arteriosclerosis | |
| CN1281228C (en) | Medicine for hyperplasia of mammary glands and its preparation | |
| CN1257745C (en) | Chinese medicinal composition for treating typhoid | |
| CN1158091C (en) | Chinese medicine composition for treating lung cancer | |
| CN115089663B (en) | Traditional Chinese medicine composition with qi-tonifying and body fluid-generating effects and preparation method thereof | |
| CN103610991B (en) | Medicine being used for the treatment of swine gastric ulcer and preparation method thereof | |
| CN1634235A (en) | Medicine for treating colitis | |
| CN1383851A (en) | Lung cancer treating medicine and its prepn | |
| CN1263499C (en) | Chinese medicine for treating cancer | |
| CN1070073C (en) | Medicine for treating hypercoagulable blood and its preparing process | |
| CN105963565A (en) | Feed additive for preventing and treating colibacillosis in minks and preparation method thereof | |
| CN113262266A (en) | Traditional Chinese medicine decoction for promoting fracture healing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |